PTU-114 Hepatology Specialist Nurse Led External Jugular Venepuncture; Is It Safe And Effective?

Abstract

Methods We aimed to review the management of patients with decompensated liver disease in the first 24 h after admission to hospital. This was a region-wide audit including all Trusts in the Northern Deanery. An audit proforma was designed and data collected on consecutive admissions over a 3 month period.Results 139 patients were included in the study; 69% male, median age 54 years (range 26-86 years). ARLD was the cause of liver disease in 88%. The median MELD score was 19 (range 6-39) and 88% had Child-Pugh Grade B or C disease. The commonest reasons for admission were ascites (28%), GI bleeding (21%), encephalopathy (19%) and jaundice (16%).There was a 9% mortality rate during the admission and average length of stay was 15 days.82 patients had clinical ascites; 62% had a diagnostic tap within 24 h of admission, 21% waited >24 h and 17% did not have a diagnostic tap. 18% had spontaneous bacterial peritonitis (SBP).Previous alcohol history was only documented in 43% but current daily consumption was documented in 81%. Of patients with documented current alcohol excess, 92% received pabrinex and 94% were started on CIWA.99% had their renal function checked on admission. 26% had renal impairment; 28% of whom did not have all their nephrotoxins stopped. Hyponatraemia (sodium <125 mmol/L) was present in 9%; 42% of whom did not have diuretics stopped.27 (19%) patients had known or suspected variceal bleeding. 19% did not receive terlipressin and 30% did not receive vitamin K. 67% of patients had an upper GI endoscopy within 12 h of admission, and 78% within 24 h.Hepatic encephalopathy was present in 32% of patients and lactulose commenced in 98%.17% of patients were not seen by a consultant (any speciality) within 12 h of admission, 7% were not seen by a gastroenterology or hepatology consultant within 72 h of admission and 39% were not seen within 24 h. Conclusion There are clear deficiencies in the acute management of patients with decompensated liver disease across the Northern region in keeping with the findings of the NCEPOD report. The findings of this audit will be shared across the region and we are instituting a 'care bundle' to focus on the key management of these patients and guide clinicians to improve patient care. We will re-audit to assess the impact of the 'care bundle' on patient care.

Jugular venipuncture and other innovative approaches to phlebotomy among people who inject drugs

“…According to Morris, Frayne et al . (), a specialist nurse‐led external jugular venipuncture service is safe, effective, and importantly, well‐received by patients.…”

“…One such innovative approach has occurred within the tertiary health setting, where currently almost all HCV treatment occurs. We are aware of a small number of hepatitis clinics within hospitals in which protocols are being developed to allow for external jugular phlebotomy (Mason et al, 2007;Morris et al, 2014). These are seen as crucial to ensure that people with difficult-to-access veins can be safely monitored throughout their HCV treatment by appropriatelyqualified nursing staff.…”

“…These are seen as crucial to ensure that people with difficult-to-access veins can be safely monitored throughout their HCV treatment by appropriatelyqualified nursing staff. According to Morris, Frayne et al (2014), a specialist nurse-led external jugular venipuncture service is safe, effective, and importantly, well-received by patients.…”